Cancer support specialist Reframe Cancer has joined the trade body Group Risk Development (Grid).
Reframe Cancer provides assistance and care services for employers and employees impacted by cancer. As well as working directly with employers, Reframe Cancer partners with insurers to deliver a personalised service to their customers affected by the disease.
According to Grid’s figures for 2023, cancer was once again the main cause of claim across all three types of group risk product, accounting for over two thirds (68 per cent) of group critical illness claims, 39 per cent of group life claims and nearly a quarter (24 per cent) of group income protection claims.
Reframe Cancer CEO Mark Stephenson says: “Grid offers us a platform to make connections and develop relationships that will help drive knowledge and awareness of cancer support, it’s impact on patient outcomes and the added value it brings to insurers and employers. We hope to collaborate with other like-minded organisations and together, create a more efficient and effective pathway for navigating cancer care.”
Grid chair Colin Fitzgerald adds: “We know that Reframe Cancer’s specialist knowledge will be invaluable to our existing members and that they will also benefit from the networking opportunities, research, and insights that are central to being a Grid member.”